Parents could save time and money by testing for strep throat at home as opposed to going to the doctor, according to a new study from the Massachusetts Institute of Technology. Beth Israel Deaconess Medical Center researchers also collaborated on the study. Streptococcus, also known as strep throat, causes a sore, red throat that is […]
Diagnostics
MobileODT raises $7m for portable cervical cancer detection device
MobileODT said today that it raised $6.8 million in a Series B financing round. OrbiMed Advisors led the financing and was joined by a previous investor, Tristel. To date, the Israeli cancer diagnostic company has raised more than $13 million. MobileODT’s device, EVA, is a cheap, portable device that uses an imaging system to detect […]
‘Nanolock’ could help diagnose and treat cancer with individualized therapies
In a study published in ACS Sensors, a team of researchers described how they develop a method to recognize a particular mutation in the genetic code of a cancerous cell. If cancers are caught early enough in the cell mutation process, many of them can be stopped with chemotherapy and other forms of treatment. This new […]
7 medtech stories we missed this week: June 30, 2017
From ConforMIS touting its knee replacement study to Consulting Radiologists’s new breast cancer detection tool, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Study: Low-dose CT scanning improves Ankylosing Spondylitis assessment A new study has shown that low-dose computed tomography (LD-CT) is more sensitive than X-rays for monitoring […]
Could dogs be better than medical devices at detecting cancer?
Dogs in a small Japan town are being trained to detect stomach cancer through their scent to try to combat the high rates of stomach cancer in the area, according to media reports. The small 6,000-resident Japanese town of Kaneyama has high rates of stomach cancer and mayor Hiroshi Suzuki has taken to a sniffer […]
SciBase wins FDA PMA nod for Nevisense malignant melanoma detector
Medical device company SciBase said today it won FDA pre-market approval for its Nevisense device designed for the early detection of malignant melanoma. The Stockholm-based company’s device is indicated for use on cutaneous lesions with 1 or more clinical or historical characteristics of melanoma, for obtaining additional information when considering a biopsy, the company said. […]
MetaStat lands $7m for personalized cancer diagnostic, therapy tech
MetaStat (OTC:MTST) said this week that it closed the 1st tranche of a $7 million private placement. The round, which was led by Perceptive Advisors, is slated to bring in approximately $2.1 million, according to the Boston-based company. Get the full story at our sister site, Drug Delivery Business News.
Insulin assay from Ortho Clinical Diagnostics nabs FDA nod
Ortho Clinical Diagnostics said yesterday that its Vitros insulin assay and calibrators won 510(k) clearance from the FDA. The Raritan, N.J.-based company reported that the diabetes and pre-diabetes diagnostic test is slated to be commercially available in the 3rd quarter of this year. Get the full story at our sister site, Drug Delivery Business News.
FDA approves diagnostic that simultaneously screens for multiple lung cancer types
The FDA said today that it awarded premarket approval to Thermo Fisher Scientific’s (NYSE:TMO) next-gen sequencing-based test that can simultaneously screen tumor samples for biomarkers associated with 3 approved therapies for non-small cell lung cancer. The company’s Oncomine Dx Target Test evaluates 23 genes associated with non-small cell lung cancer. The tests results could help […]
Imagion Biosystems raises $9m with Aussie IPO
Imagion Biosystems (ASX:IBX) said today that it raised $9.1 million (A$12 million) in an initial public offering on the Australian stock exchange for its MagSense cancer-tagging nanoparticles. The 15.1¢-per-share (A20¢) flotation of 60 million shares is earmarked for 1st-in-human trials, expected during the 2nd half of 2018, the Albuquerque-based company said. The MagSense nanoparticles have a […]
Impedimed wins CE Mark for Sozo monitoring system
Australian medtech developer ImpediMed said today it won CE Mark approval in the European Union for its Sozo bioimpedance spectroscopy platform. The Sozo system is designed to non-invasively measure and monitor fluid status and body composition using the company’s L-Dex lateral lymphedema assessment system. With the clearance, the Sozo platform is indicated for use as a bioimpedance […]